// App-Quantinova.ai

TCT-584 : Nine Month Imaging and Twelve Month Clinical Results from the DESSOLVE II Randomized Trial of the MiStent SES with Absorbable Polymer

Researchers

Presenter

  • William Wijns

Principal Investigators

  • Mathias Vrolix

  • Stefan Verheye

  • Peter Fitzgerald

  • Danny Schoors

  • Ton Slagboom

  • Marcel Gosselink

  • Edouard Benit

  • Walter Desmet

  • Saquib Chowdhary

  • Alexandra Lansky

  • Hiram Bezerra

Medical Centers

  • Case Western Reserve University, Cleveland, OH

  • Katholieke Universiteit Leuven, Leuven, Belgium

  • Antwerp Cardiovascular Center, Antwerp, Belgium

  • Erasme University Hospital, Brussels, Belgium

  • Stanford Univeresity Medical Center, Stanford, CA

  • Onze Lieve Vrouwe Gasthuis, Amsterdam, Noord-Holland, Netherlands

  • Wythenshawe Hospital, Manchester, United Kingdom

  • Cardiovascular Center Aalst, Belgium, Aalst, Belgium

  • Hospital East-Limburg, Genk, Belgium

  • Mercy Angiography, Auckland, New Zealand

  • Isala Clinics, Zwolle, Netherlands

Locations

  • Netherlands

  • United Kingdom

  • United States

  • Belgium

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

  • ZoMaxx

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved